Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CPH NASDAQ:CRON NYSEARCA:THCX NASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$15.10-1.0%C$13.24C$10.61▼C$19.69C$271.10M1.228,436 shs17,832 shsCRONCronos Group$2.60+1.6%$2.12$1.60▼$2.77$980.58M1.013.09 million shs2.79 million shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/ATLRYTilray Brands$1.15+3.6%$0.66$0.35▼$1.95$1.22B1.8576.17 million shs51.16 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals-1.05%+6.19%+18.71%+21.58%-5.27%CRONCronos Group+1.56%+9.70%+24.40%+28.08%+8.79%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+3.60%+11.65%+56.23%+159.95%-39.15%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPHCipher Pharmaceuticals0.6687 of 5 stars1.20.00.00.01.61.71.3CRONCronos Group0.7375 of 5 stars0.03.00.00.02.00.01.3THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands2.4334 of 5 stars3.11.00.00.03.21.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPHCipher Pharmaceuticals 2.33HoldC$14.75-2.32% DownsideCRONCronos Group 0.00N/AN/AN/ATHCXAXS Cannabis ETF 2.57Moderate Buy$16.60N/ATLRYTilray Brands 2.20Hold$1.9266.67% UpsideCurrent Analyst Ratings BreakdownLatest CPH, THCX, TLRY, and CRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/29/2025TLRYTilray BrandsZelman & AssociatesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPHCipher PharmaceuticalsC$19.03M14.24C$4.28 per share3.53C$3.96 per share3.81CRONCronos Group$117.61M8.47$0.00 per share5,501.59$2.95 per share0.88THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ATLRYTilray Brands$821.31M1.54$0.15 per share7.68$1.40 per share0.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPHCipher PharmaceuticalsC$11.41MC$0.9116.68∞N/A59.92%17.93%7.90%N/ACRONCronos Group$41.08M$0.0552.0086.67N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)THCXAXS Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)Latest CPH, THCX, TLRY, and CRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPHCipher PharmaceuticalsN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPHCipher Pharmaceuticals41.222.002.67CRONCronos GroupN/A24.6523.53THCXAXS Cannabis ETFN/AN/AN/ATLRYTilray Brands0.202.461.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPHCipher Pharmaceuticals1.38%CRONCronos Group8.71%THCXAXS Cannabis ETFN/ATLRYTilray Brands9.35%Insider OwnershipCompanyInsider OwnershipCPHCipher Pharmaceuticals42.00%CRONCronos Group7.30%THCXAXS Cannabis ETFN/ATLRYTilray Brands0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPHCipher Pharmaceuticals517.95 millionN/ANot OptionableCRONCronos Group450383.04 million355.08 millionOptionableTHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableTLRYTilray Brands2,8421.10 billion1.09 billionOptionableCPH, THCX, TLRY, and CRON HeadlinesRecent News About These CompaniesTilray Brands (NASDAQ:TLRY) Trading Up 2.3% - What's Next?2 hours ago | marketbeat.comTilray Brands, Inc. (NASDAQ:TLRY) Given Average Recommendation of "Hold" by AnalystsAugust 23 at 3:41 AM | marketbeat.comTilray Brands (NASDAQ:TLRY) Stock Price Up 3.3% - Here's What HappenedAugust 22 at 1:46 PM | marketbeat.comTilray Brands (NASDAQ:TLRY) Trading Down 3.3% - Time to Sell?August 21 at 3:37 PM | marketbeat.comTilray's High Hopes: The Catalyst Driving Cannabis Stocks...August 21 at 2:09 PM | marketbeat.comTop Cannabis Stocks To Watch Today - August 20thAugust 21 at 1:11 PM | marketbeat.comUnleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused ElixirAugust 21 at 7:00 AM | globenewswire.comTilray Brands (NASDAQ:TLRY) Trading Down 7.5% - Time to Sell?August 20 at 3:05 PM | marketbeat.comCannabis Stocks To Follow Today - August 19thAugust 20 at 1:01 PM | marketbeat.comTilray Shares Blazing: What's Behind the 55% Rally This Month?...August 20 at 11:25 AM | marketbeat.comIf You'd Invested $1,000 in Tilray Stock 5 Years Ago, Here's How Much You'd Have TodayAugust 20 at 7:01 AM | fool.comTilray Brands (NASDAQ:TLRY) Shares Up 9.2% - Time to Buy?August 19, 2025 | marketbeat.comPromising Cannabis Stocks To Add to Your Watchlist - August 18thAugust 19, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Shares Gap Up - Here's WhyAugust 19, 2025 | marketbeat.comTilray Brands (NASDAQ TLRY) Rises Amid NASDAQ Composite Market TrendsAugust 19, 2025 | kalkinemedia.comKPromising Cannabis Stocks To Add to Your Watchlist - August 17thAugust 18, 2025 | marketbeat.comNational Bank of Canada FI Sells 763,247 Shares of Tilray Brands, Inc. $TLRYAugust 18, 2025 | marketbeat.comTilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage ProductsAugust 17, 2025 | insidermonkey.comCannabis Stocks Worth Watching - August 16thAugust 17, 2025 | marketbeat.comBest Canadian Cannabis Stocks in 2025August 17, 2025 | marijuanastocks.comMTilray Brands (NASDAQ:TLRY) Trading Down 7.2% - Here's What HappenedAugust 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Why the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025Tilray's High Hopes: The Catalyst Driving Cannabis StocksBy Jeffrey Neal Johnson | August 21, 2025CPH, THCX, TLRY, and CRON Company DescriptionsCipher Pharmaceuticals TSE:CPHC$15.10 -0.16 (-1.05%) As of 08/22/2025 04:00 PM EasternCipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.Cronos Group NASDAQ:CRON$2.60 +0.04 (+1.56%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.61 +0.01 (+0.23%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.Tilray Brands NASDAQ:TLRY$1.15 +0.04 (+3.60%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.14 0.00 (-0.43%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.